Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices, including the funding-lapse notice and Revision: v3.4.1, have been removed.SummaryDifference0.5%

- Check43 days agoChange DetectedA government funding lapse notice is now displayed and the site version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedShow glossary added; a new 'Last Update Submitted that Met QC Criteria' metadata field appears; and footer notes updated to reflect No FEAR Act data with revision 3.4.0. The previous version referenced revision 3.3.4 and No FEAR Act data wording.SummaryDifference0.3%

- Check65 days agoChange DetectedMinor system revision updated from v3.3.3 to v3.3.4; no user-facing content or study information appears to have changed.SummaryDifference0.1%

- Check86 days agoChange DetectedFooter changes: Revision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.